Search Within

Mark Donoghue

Formats
  1. Journal Article (55)
  2. Meeting Abstract (34)
  3. Research Letter (2)
  4. Review (2)
  5. Guidelines (1)
Groups
  1. Department of Medicine (93)
  2. Solid Tumor Oncology Division (91)
  3. GSK Faculty (85)
  4. Department of Pathology and Laboratory Medicine (79)
  5. Human Oncology and Pathogenesis Program (73)
  6. Weinberg Fellows (70)

More Groups

People
  1. David Solit (41)
  2. Michael Berger (37)
  3. Barry Taylor (30)
  4. Chaitanya Bandlamudi (26)
  5. Marc Ladanyi (25)
  6. Allison Richards (20)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (12)
  4. 2022 (17)
  5. 2021 (9)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Clinical Cancer Research (14)
  3. JCO Precision Oncology (7)
  4. Cancer Research (5)
  5. Annals of Oncology (4)
  6. Cancer Cell (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. American Association for Cancer Research (25)
  3. Nature Publishing Group (10)
  4. Cell Press (8)
  5. Elsevier Inc. (5)
  6. Oxford University Press (5)

More Publishers

Results (94)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pan-cancer analysis of SMARCA4 alterations and the unique clinicogenomic characteristics associated with SMARCA4 mutation types
    Meeting Abstract

    Gormally, M.; Repetto, M.; Jee, J.; Chang, J. C.; Selenica, P.; Gazzo, A.; Richards, A. L.; Donoghue, M.; Aghajanian, C.; Reis-Filho, J. S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline and somatic MUTYH mutations: Clinicopathologic and mutational analysis in a pan-cancer cohort
    Meeting Abstract

    Desilets, A.; Repetto, M.; Kemel, Y.; Khurram, A.; Mandelker, D.; Bandlamudi, C.; Novak, B.; Velilla, C.; Selenica, P.; Richards, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Serial cell-free DNA sequencing in ROS1 fusion-positive lung cancers during treatment with entrectinib
    Journal Article

    Choudhury, N. J.; Woo, H. J.; Chen, M.; Shah, R.; Donoghue, M.; Berger, M.; Drilon, A.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
    Journal Article

    Lin, A. L.; Rudneva, V. A.; Richards, A. L.; Zhang, Y.; Woo, H. J.; Cohen, M.; Tisnado, J.; Majd, N.; Wardlaw, S. L.; Page-Wilson, G.; more...
    Acta Neuropathologica (2024)

    Fulltext@MSK | Save
  • Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy
    Journal Article

    Walmsley, C. S.; Jonsson, P.; Cheng, M. L.; McBride, S.; Kaeser, C.; Vargas, H. A.; Laudone, V.; Taylor, B. S.; Kappagantula, R.; Baez, P.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Prevalence and clinical implications of mismatch repair-proficient colorectal cancer in patients with Lynch syndrome
    Journal Article

    Ranganathan, M.; Sacca, R. E.; Trottier, M.; Maio, A.; Kemel, Y.; Salo-Mullen, E.; Catchings, A.; Kane, S.; Wang, C.; Ravichandran, V.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers
    Meeting Abstract

    Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save